Collegium Pharmaceutical Inc’s recently made public that its Director BOHLIN GAREN G unloaded Company’s shares for reported $0.94 million on May 14 ’24. In the deal valued at $32.30 per share,28,985 shares were sold. As a result of this transaction, BOHLIN GAREN G now holds 44,775 shares worth roughly $1.54 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Smith Thomas B sold 995 shares, generating $36,580 in total proceeds. Upon selling the shares at $36.76, the EVP and Chief Medical Officer now owns 63,409 shares.
Before that, Dreyer Scott sold 10,000 shares. Collegium Pharmaceutical Inc shares valued at $364,270 were divested by the EVP & Chief Commercial Officer at a price of $36.43 per share. As a result of the transaction, Dreyer Scott now holds 138,918 shares, worth roughly $4.79 million.
Piper Sandler downgraded its Collegium Pharmaceutical Inc [COLL] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in early May from “a Buy” to “a Hold”. Jefferies also remained covering COLL and has decreased its forecast on January 04, 2024 with a “Hold” recommendation from previously “Buy” rating. Needham maintained its rating on August 25, 2023. It rated COLL as “a Buy”.
Price Performance Review of COLL
On Tuesday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 1.02% to $34.50. Over the last five days, the stock has gained 3.63%. Collegium Pharmaceutical Inc shares have risen nearly 12.09% since the year began. Nevertheless, the stocks have risen 48.26% over the past one year. While a 52-week high of $40.95 was reached on 03/28/24, a 52-week low of $20.83 was recorded on 05/10/24. SMA at 50 days reached $36.98, while 200 days put it at $29.82. A total of 0.32 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 34.14, which if violated will result in even more drops to 33.77. On the upside, there is a resistance level at 34.86. A further resistance level may holdings at 35.22. The Relative Strength Index (RSI) on the 14-day chart is 46.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.12%. Stochastics %K at 40.18% indicates the stock is a holding.
